Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MANNKIND CORPMNKD · Entity 4792 | EVP Genl Counsel & Secretary | July 15, 2026 | July 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MANNKIND CORP
Report date July 15, 2026 · Filed July 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 Par ValueSEC Table I · non-derivative | Direct | 920,089 |
Reported balance
After 2026-07-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-15 · Exercise / conversion · Acquired 93,790 · Balance 920,089 F1: A previously reported restricted stock unit award granted on May 25, 2023 vested on July 15, 2026 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on June 30, 2026 was not less than the closing price on May 25, 2023 and (ii) MannKind's total shareholder return (TSR) over the period from May 23, 2023 to June 30, 2026 was at the 41.5th percentile of the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period. As a result, the performance objective was achieved at 83% of target, resulting in a total share delivery of 93,790 shares. The acquisition of 113,000 shares pursuant to the restricted stock award was reported in Table II of the Form 4 filed by the Reporting Person on May 26, 2023. The remaining 19,210 shares were forfeited in accordance with the performance vesting criteria. |
| Common Stock, $0.01 Par ValueSEC Table I · non-derivative | Direct | 868,457 |
Reported balance
After 2026-07-15 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-07-15 · Tax withholding · Disposed 51,632 · Balance 868,457 F2: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. |
| Common Stock, $0.01 Par ValueSEC Table I · non-derivative | Direct | 855,795 |
Reported balance
After 2026-07-15 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-07-15 · Tax withholding · Disposed 12,662 · Balance 855,795 F2: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. |
| Common Stock, $0.01 Par ValueSEC Table I · non-derivative | Direct | 838,041 |
Reported balance
After 2026-07-15 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-07-15 · Tax withholding · Disposed 17,754 · Balance 838,041 F2: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. |
| Common Stock, $0.01 Par ValueSEC Table I · non-derivative | Direct | 821,663 |
Reported balance
After 2026-07-15 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2026-07-15 · Tax withholding · Disposed 16,378 · Balance 821,663 F2: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. |
| Common Stock, $0.01 Par ValueSEC Table I · non-derivative | Direct | 797,554 |
Reported balance
After 2026-07-17 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2026-07-17 · Sale · Disposed 24,109 · Balance 797,554 F4: The weighted average sales price of the reported transaction was $4.05 based on a range of prices between $3.98 and $4.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F3: Transaction occurred pursuant to Rule 10B5-1 Plan established December 2, 2025. |
| Performance Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-07-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-07-15 · Exercise / conversion · Disposed 93,790 · Balance 0 F5: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F1: A previously reported restricted stock unit award granted on May 25, 2023 vested on July 15, 2026 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on June 30, 2026 was not less than the closing price on May 25, 2023 and (ii) MannKind's total shareholder return (TSR) over the period from May 23, 2023 to June 30, 2026 was at the 41.5th percentile of the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period. As a result, the performance objective was achieved at 83% of target, resulting in a total share delivery of 93,790 shares. The acquisition of 113,000 shares pursuant to the restricted stock award was reported in Table II of the Form 4 filed by the Reporting Person on May 26, 2023. The remaining 19,210 shares were forfeited in accordance with the performance vesting criteria. |
Filing footnotes · ownership attribution and instrument terms
F1: A previously reported restricted stock unit award granted on May 25, 2023 vested on July 15, 2026 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on June 30, 2026 was not less than the closing price on May 25, 2023 and (ii) MannKind's total shareholder return (TSR) over the period from May 23, 2023 to June 30, 2026 was at the 41.5th percentile of the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period. As a result, the performance objective was achieved at 83% of target, resulting in a total share delivery of 93,790 shares. The acquisition of 113,000 shares pursuant to the restricted stock award was reported in Table II of the Form 4 filed by the Reporting Person on May 26, 2023. The remaining 19,210 shares were forfeited in accordance with the performance vesting criteria.
F2: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
F3: Transaction occurred pursuant to Rule 10B5-1 Plan established December 2, 2025.
F4: The weighted average sales price of the reported transaction was $4.05 based on a range of prices between $3.98 and $4.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
F5: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 10, 2023 Filed May 13, 2023 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 7,781 | $4.40 | $34,236.40 |
DisclosureSEC source: 0001209191-23-029238 · doc4.xml · nonDerivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 718,254 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 29, 2022 Filed Aug 30, 2022 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | SaleCommon Stock, $.01 Par Value | 7,000 | $3.67 | $25,690.00 |
DisclosureSEC source: 0001209191-22-047943 · doc4.xml · nonDerivative · entry 2 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 726,035 F2 · kind: Transaction occurred pursuant to Rule 10B5-1 Plan to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 27, 2022 Filed Aug 30, 2022 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 14,178 | $3.73 | $52,883.94 |
DisclosureSEC source: 0001209191-22-047943 · doc4.xml · nonDerivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 733,035 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| May 18, 2022 Filed May 21, 2022 00:00 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 6,001 | $3.19 | $19,143.19 |
DisclosureSEC source: 0001209191-22-031199 · doc4.xml · nonDerivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 747,213 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| May 10, 2022 Filed May 13, 2022 00:01 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 110,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028677 · doc4.xml · nonDerivative · entry 2 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 753,214 F3 · shares: The restricted stock unit will vest on May 10, 2025 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on May 10, 2022. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from May 10, 2022 until May 10, 2025 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| May 10, 2022 Filed May 13, 2022 00:01 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028677 · doc4.xml · nonDerivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 643,214 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| August 27, 2021 Filed Aug 28, 2021 01:01 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 14,177 | $4.91 | $69,609.07 |
DisclosureSEC source: 0001209191-21-053771 · doc4.xml · nonDerivative · entry 2 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 553,214 F2 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 27, 2021 Filed Aug 28, 2021 01:01 UTC | MANNKIND CORP MNKD · Entity 4792 | SaleCommon Stock, $.01 Par Value | 4,100 | $4.64 | $19,024.00 |
DisclosureSEC source: 0001209191-21-053771 · doc4.xml · nonDerivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 567,391 F1 · kind: Transaction occurred pursuant to Rule 10B5-1 Plan to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 79,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034453 · doc4.xml · nonDerivative · entry 2 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 571,491 F3 · shares: The restricted stock unit will vest on May 17, 2024 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on May 17, 2021. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from May 18, 2021 until May 17, 2024 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 69,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034453 · doc4.xml · nonDerivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,491 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 23:09 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048849 · doc4.xml · nonDerivative · entry 2 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423,079 F3 · shares: The restricted stock unit will vest on May 22, 2023 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on August 27, 2020. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from August 27, 2020 until May 22, 2023 related to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 23:09 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 164,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048849 · doc4.xml · nonDerivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,079 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 11:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 37,525 | $1.42 Strike: $1.42 | $53,285.50 |
DisclosureSEC source: 0001209191-20-013627 · doc4.xml · derivative · entry 2 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,525 Underlying: Stock Options · 37,525 shares Expires 2027-05-25 F2 · kind: On May 25, 2017, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 25, 2020, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 11:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 20,000 | $4.55 Strike: $4.55 | $91,000.00 |
DisclosureSEC source: 0001209191-20-013627 · doc4.xml · derivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Stock Options · 20,000 shares Expires 2026-05-19 F1 · kind: On May 19, 2016, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 25, 2020, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 22:56 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 17,830 | $1.51 | $26,923.30 |
DisclosureSEC source: 0001209191-20-011693 · doc4.xml · nonDerivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,079 F1 · shares: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 27, 2019 Filed Aug 30, 2019 00:29 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 329 | $1.06 | $348.74 |
DisclosureSEC source: 0001209191-19-047774 · doc4.xml · nonDerivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,909 F1 · kind: Shares withheld to satisfy the tax withholding obligation applicable to the vesting of 805 previously reported restricted stock units. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:21 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 234,000 | $1.32 Strike: $1.32 | $308,880.00 |
DisclosureSEC source: 0001209191-19-030368 · doc4.xml · derivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,000 Underlying: Stock Options · 234,000 shares Expires 2029-05-14 F1 · kind: Annual Equity Award: 25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. Read SEC document |
| February 20, 2019 Filed Feb 25, 2019 11:11 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 43,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-012818 · doc4.xml · nonDerivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,238 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Restricted stock units shall vest and be delivered on February 20, 2020. Read SEC document |
| August 28, 2018 Filed Feb 15, 2019 00:53 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $0.01 Par Value | 278 | $1.12 | $311.36 |
DisclosureSEC source: 0001209191-19-010450 · doc5.xml · nonDerivative · entry 2 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,622 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 21, 2018 Filed Feb 15, 2019 00:53 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $0.01 Par Value | 167 | $1.11 | $185.37 |
DisclosureSEC source: 0001209191-19-010450 · doc5.xml · nonDerivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,900 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 23:20 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 37,525 | $1.42 Strike: $1.42 | $53,285.50 |
DisclosureSEC source: 0001209191-18-045605 · doc4.xml · derivative · entry 2 Thomson David · CIK 0001297976 · Corp VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,525 Underlying: Stock Options · 37,525 shares Expires 2027-05-25 F2 · kind: On May 25, 2017, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On August 2, 2018, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 23:20 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 20,000 | $4.55 Strike: $4.55 | $91,000.00 |
DisclosureSEC source: 0001209191-18-045605 · doc4.xml · derivative · entry 1 Thomson David · CIK 0001297976 · Corp VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Stock Options · 20,000 shares Expires 2026-05-19 F1 · kind: On May 19, 2016, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On August 2, 2018, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| May 16, 2018 Filed May 18, 2018 14:18 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 214,000 | $1.91 Strike: $1.91 | $408,740.00 |
DisclosureSEC source: 0001209191-18-031289 · doc4.xml · derivative · entry 1 Thomson David · CIK 0001297976 · Corp VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,000 Underlying: Stock Options · 214,000 shares Expires 2028-05-16 F1 · kind: 25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. Read SEC document |
| August 28, 2017 Filed Aug 30, 2017 01:08 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 303 | $1.55 | $469.65 |
DisclosureSEC source: 0001209191-17-050659 · doc4.xml · nonDerivative · entry 1 Thomson David · CIK 0001297976 · Corp VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,067 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 23:08 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 170 | $1.41 | $239.70 |
DisclosureSEC source: 0001209191-17-050011 · doc4.xml · nonDerivative · entry 2 Thomson David · CIK 0001297976 · Corp VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,370 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 23:08 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 183 | $1.46 | $267.18 |
DisclosureSEC source: 0001209191-17-050011 · doc4.xml · nonDerivative · entry 1 Thomson David · CIK 0001297976 · Corp VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,540 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.